The North America medical robots market is expected to grow from US$ 3,982.30 million in 2022 to US$ 11,112.23 million by 2028; it is estimated to grow at a CAGR of 18.7% from 2022 to 2028, according to The “North America Medical Robots Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Product, Application, and End User” by ResearchAndMarkets.com.
The medical robots market is experiencing various changes in the technology landscape that enable players to develop innovative products. State-of-the-art products may assist in conferring improved health conditions, thereby allowing people to live better lives. Leading companies consolidate the market through various R&D activities to offer modern products.
For instance, in December 2021, Inrobics Social Robotics introduced an AI-based robotic device to aid health rehabilitation. Further, in November 2019, Toyota Motor Corporation (Toyota) introduced the Welwalk WW-2000, a robot aimed to assist patients with lower-limb paralysis caused by stroke or other causes. Hence, the rising product launches are supporting market expansion across the region. Moreover, the surging number of surgical procedures is expected to drive the market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America medical robots market . The North America medical robots market is expected to grow at a good CAGR during the forecast period.